07:00 , Apr 25, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Cytomegalovirus (CMV) ATP-binding cassette sub-family C member 1 (ABCC1; MRP; MRP1) Cell culture studies suggest cytotoxic drugs such as vincristine could help prevent cytomegalovirus...
07:00 , Oct 3, 2011 |  BC Week In Review  |  Company News

Cleveland BioLabs, Rusnano OJSC cancer, infectious news

Cleveland BioLabs and the Russian Federation's Rusnano will form a JV called Panacela Labs Inc. (Buffalo, N.Y.) to develop and commercialize products for cancer and infectious diseases. Rusnano will invest up to $26 million in...
07:00 , Jun 23, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Hypertension ATP-binding cassette sub-family C member 4 (ABCC4; MRP4) Studies in mice and in patient samples suggest inhibiting MRP4 could help treat pulmonary arterial...
07:00 , Oct 4, 2010 |  BC Week In Review  |  Clinical News

PreFluCel influenza vaccine regulatory update

The Austrian Agency for Health and Food Safety (AGES) approved PreFluCel seasonal influenza vaccine from Baxter. The non-adjuvanted trivalent seasonal influenza vaccine is produced using Baxter's Vero cell culture technology. Baxter plans to submit applications...
00:56 , Sep 30, 2010 |  BC Extra  |  Company News

Baxter's PreFluCel approved in Austria

The Austrian Agency for Health and Food Safety (AGES) approved PreFluCel seasonal influenza vaccine from Baxter International Inc. (NYSE:BAX). The non-adjuvanted trivalent seasonal influenza vaccine is produced using Baxter's Vero cell culture technology. Baxter plans...
07:00 , Jun 3, 2010 |  BC Innovations  |  Distillery Techniques

Technology: Drug delivery

Drug delivery Inhaled drug delivery system for lung cancer treatment In vitro and mouse studies suggest that inhaled doxorubicin plus inhibitors of two different drug-resistance mechanisms could help treat lung cancer. In human lung cancer...
07:00 , May 20, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune disease; lupus S100 calcium binding protein A8 (S100A8; calgranulin A; MRP8); S100A9 (calgranulin B; MRP14) Studies in mice and in humans suggest that...
07:00 , Apr 22, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Hodgkin's disease ATP-binding cassette sub-family C member 1 (ABCC1; MRP; MRP1) Genetic studies identified copy number variations associated with Hodgkin's lymphoma and suggest that blocking...
07:00 , Sep 10, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication:

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer ATP-binding cassette sub-family C member 1 (ABCC1; MRP; MRP1) In vitro studies identified a series of flavonoid homodimers that could help reduce multidrug...
07:00 , Apr 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer UDP glucuronosyltransferase 1 family, polypeptide A1 (UGT1A1); ATP-binding cassette sub-family C (CFTR/MRP) member 1 (ABCC1) A study in patient...